Dendritic cell-based immunotherapy for prostate cancer.
Nov 2010 - Clin. Dev. Immunol.; 2010:1740-2530 [PMID:21076523]
[Jähnisch H] [Füssel S] [Kiessling A] [Wehner R] [Zastrow S] [Bachmann M] [Rieber EP] [Wirth MP] [Schmitz M]

Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial.
Apr 2006 - Prostate; 66(8):0270-4137 [PMID:16482569]
[Fuessel S] [Meye A] [Schmitz M] [Zastrow S] [Linné C] [Richter K] [Löbel B] [Hakenberg OW] [Hoelig K] [Rieber EP] [Wirth MP]